Toxic epidermal necrolysis — an investigation to dye for?

Correspondence: lloyd.ridley@sswahs.nsw.gov.au

Competing interests:

No relevant disclosures.

1. Ly T, Stewart N, Lee S. Toxic epidermal necrolysis — an investigation to dye for? Med J Aust 2015; 202: 51-52. <MJA full text>
2. Department of Health (Australia): Therapeutic Goods Administration. About the DAEN — medicines [website]. http://www.tga.gov.au/about-daen-medicines (accessed Feb 2015).
3. American College of Radiology. ACR manual on contrast media. Version 9. ACR, 2013. http://www.acr.org/quality-safety/resources/contrast-manual (accessed May 2015).
4. Schwartz RA, McDonough PH, Lee BW. Toxic epidermal necrolysis: part I. Introduction, history, classification, clinical features, systemic manifestations, etiology and immunopathogenesis. J Am Acad Dermatol 2013; 69: 173.e1-173.e13.
5. Sassolas B, Haddad C, Mockenhaupt M, et al. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharm Ther 2010; 88: 60-68.
6. Webb JA, Stacul F, Thomsen HS, Morcos SK; members of the Contrast Media Safety Committee of the European Society of Urogenital Radiology. Late adverse reactions to intravascular iodinated contrast media. Eur Radiol 2003; 13: 181-184.

Online responses are no longer available. Please refer to our instructions for authors page for more information.